Conferences | ASCRS
Here's the latest innovations at Neurotech Pharmaceuticals, Inc.
Rich Small, CPA, CEO of Neurotech Pharmaceuticals, Inc., shares what's in the pipeline for retina, glaucoma therapies.
Related Content:
